Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-1268P** is a human pseudogene corresponding to the U6 small nuclear RNA gene family. U6 snRNA is a highly conserved small nuclear RNA that forms part of the spliceosome and is essential for the splicing of pre-mRNA[3]. Pseudogenes like RNU6-1268P do not produce functional snRNA and are considered genomic remnants; most are not expressed or are expressed at very low levels. Some pseudogenes in other gene families can have regulatory roles, such as acting as molecular sponges for microRNAs or participating in non-coding RNA regulation, but no such function is reported for RNU6-1268P[4]. It is not recognized as a therapeutic target, nor is it associated with drug interaction, disease biomarker status, or safety considerations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1268, pseudogene (RNU6-1268P).